DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "US Mesothelioma Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.
US Mesothelioma Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Mesothelioma pipeline products, Mesothelioma epidemiology, Mesothelioma market valuations and forecast, Mesothelioma products sales and competitive landscape in the US.
The research is classified into nine sections - Mesothelioma overview including etiology, pathophysiology, and diagnosis, Mesothelioma treatment options, Mesothelioma pipeline products, Mesothelioma market analysis comprising of Mesothelioma epidemiology, key products marketed for Mesothelioma, market valuations and forecast, products sales and market shares.
- Mesothelioma Pipeline: Find out the products in clinical trials for the treatment of Mesothelioma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
- Mesothelioma Epidemiology: Find out the number of patients diagnosed (prevalence) with Mesothelioma in the US
- Mesothelioma Products: Identify key products marketed and prescribed for Mesothelioma in the US, including trade name, molecule name, and company
- Mesothelioma Product Sales: Find out the sales revenues of Mesothelioma products, both branded and generics, in the US
- Mesothelioma Market Valuations: Find out the market size for Mesothelioma products in 2015 in the US. Find out how the market advanced from 2010 and forecast to 2020
- Mesothelioma Products Market Share: Find out the market shares for key Mesothelioma products in the US
Key Topics Covered:
- Disease Overview
- Mesothelioma Treatments
- Mesothelioma Pipeline
- US Mesothelioma Epidemiology
- Marketed Drugs for Mesothelioma in US
- US Mesothelioma Market Size
- US Mesothelioma Products Sales
- US Mesothelioma Market Competitive Landscape
- US Mesothelioma Market Forecast
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/dtp58j/us_mesothelioma